Unexpected tarlatamab efficacy and toxicity in atypical carcinoid and large cell neuroendocrine carcinoma, and DLL3 level as a potential biomarker

JTO Clinical and Research Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles